Cabbacis, a tobacco company focused on novel product development, has announced the filing of trademark applications for its patent-pending X95 cigarette. This product is described by the company as containing approximately 95% less nicotine than conventional commercial cigarettes and notably contains no hemp. The trademark applications cover the United States and a broad range of international markets including Europe, the UK, China, Japan, India, Indonesia, the Philippines, South Korea, Australia, New Zealand, Canada, Mexico, Chile, and Brazil.

Industry and Regulatory Context

The introduction of very-low-nicotine cigarettes such as the X95 aligns with ongoing research and regulatory interest in nicotine reduction as a potential tobacco control strategy. Regulatory bodies in the UK and internationally continue to monitor developments in tobacco products that modify nicotine content, though nicotine and tobacco products remain subject to strict age restrictions and recognised health risks.

While Cabbacis highlights the nicotine reduction in the X95 cigarette, it is important to distinguish between verified scientific findings and trade claims. Current UK tobacco regulation does not endorse or confirm any health benefits or reduced harm claims associated with very-low-nicotine cigarettes. Consumers and stakeholders should remain aware that all tobacco and nicotine products carry inherent risks.

Market and Research Implications

  • The trademark filings indicate Cabbacis’s intention to commercialise the X95 cigarette widely, including in the UK and European markets where tobacco product regulation is stringent.
  • The product’s nicotine reduction may attract research interest, particularly in how such cigarettes impact user behaviour and nicotine dependence.
  • Ongoing scientific evaluation is essential to understand the public health implications of very-low-nicotine cigarettes and their role within tobacco harm reduction debates.

For more detailed updates and insights on tobacco product developments, regulation, and research, visit https://cigarettesandbaccy.com.

Editorial note: Tobacco and nicotine products are age-restricted and harmful. This article does not endorse or promote tobacco use.